Who published this market news?

TradingView published this market news item.

Lifecore Biomedical faces $52.1M Series A preferred redemption due Dec. 28, 2026

Lifecore Biomedical announced holders submitted notices to redeem all 49,263 shares of its Series A preferred, creating a roughly $52.1 million redemption obligation due December 28, 2026.Key Highlights:Original SEC Filing: LIFECORE BIOMEDICAL, INC. \DE\ [ LFCR ] - 8-K - Jul. 02, 2026This is an AI…

Lifecore Biomedical announced holders submitted notices to redeem all 49,263 shares of its Series A preferred, creating a roughly $52.1 million redemption obligation due December 28, 2026.

Key Highlights:

Holders submitted redemption notices for all 49,263 outstanding Series A preferred shares on June 29–30, 2026.
Redemption price is $1,000 per share plus accrued dividends; total liquidation value ~ $50.2M and accrued dividends $0.9M.
Total required payout on Dec. 28, 2026 (180 days) is ~ $52.1M; unpaid balances accrue 1% monthly interest thereafter.
Company had $38.1M liquidity as of Mar. 31, 2026 and is evaluating cash, financing or strategic alternatives and lender consents to facilitate payment.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.